Jeffrey Lawrence Schwartz - 04 Sep 2025 Form 4 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: KMTS
Reported as of: 04 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Sep 2025, 17:27:57 UTC
Prior SEC filing: 06 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey Schwartz

Key filing fact

Jeffrey Lawrence Schwartz filed Form 4 for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) on 08 Sep 2025.

Key facts

This page summarizes Jeffrey Lawrence Schwartz's Form 4 filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Sep 2025, 17:27.

Change

Previous filing in this sequence was filed on 06 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001702957 Primary reporting owner

Schwartz Jeffrey Lawrence

Relationship: Director, 10%+ Owner
Address: C/O BAIN CAPITAL INVESTORS, LLC, 200 CLARENDON STREET, BOSTON
Signature: /s/ Jeffrey Schwartz
Signature date: 08 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KMTS transaction

Common Shares

Award

Transaction value
Shares: +10,909
Change %
Price
Shares after: 10,909
Date: 04 Sep 2025
Ownership: Direct
Footnotes: F1

KMTS holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 27,019,225
Date: 04 Sep 2025
Ownership: See footnote
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

Footnote F2

Represents 7,109,944 common shares of the Issuer held directly by Bain Charger Holdings, L.P. ("Bain Charger') and 19,909,281 common shares of the Issuer held directly by West Affum Holdings, L.P. ("West Affum"). Bain Charger is the sole shareholder of West Affum GP Ltd., which is the general partner of West Affum. Mr. Schwartz is a Partner of Bain Capital Investors, LLC, which is the general partner of Bain Charger. As a result, Mr. Schwartz may be deemed to share voting and dispositive power with respect to the securities held by Bain Charger and West Affum. Mr. Schwartz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.